A prospective study of oesophageal 24-h ambulatory pH monitoring in patients with functional dyspepsia

Digestive and Liver Disease

Volumn 37, Issue 2, 2005, Pages 87-91

  Gerson, L B ^a,b   Triadafilopoulos, G ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

24 h Ambulatory oesophageal pH monitoring; Non ulcer dyspepsia

Indexed keywords

OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; ANTIULCER AGENT;

ADULT; AMBULATORY MONITORING; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DYSPEPSIA; ESOPHAGUS BIOPSY; ESOPHAGUS PH; FEMALE; HELICOBACTER PYLORI; HUMAN; MALE; PREDICTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SYMPTOMATOLOGY; COMPARATIVE STUDY; ESOPHAGUS; MIDDLE AGED; MONITORING; PATHOPHYSIOLOGY; PH; TREATMENT OUTCOME;

ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; DYSPEPSIA; ESOPHAGUS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; MONITORING, AMBULATORY; MONITORING, PHYSIOLOGIC; OMEPRAZOLE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 20544442066     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2004.09.021     Document Type: Article

References (18)

1. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. In: Drossman D, Corazziari E, Talley NJ, Thompson WG, Whitehead, WE, editors. Rome II: The functional gastrointestinal disorders. Allen Press; 2000. p. 299-350.
2. N.J. Talley K. Lauritsen The potential role of acid suppression in functional dyspepsia: The BOND, OPERA, PILOT, and ENCORE studies Gut 50 2002 36-41
3. E. Dimenas H. Glise B. Hallerback H. Hernqvist J. Svedlund I. Wiklund Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol 28 1993 681-687
4. W.E. Whitehead G. Bassotti O. Palsson E. Taub E.C. Cook III D.A. Drossman Factor analysis of bowel symptoms in US and Italian populations Dig Liver Dis 35 2003 774-783
5. J.R. Jamieson H.J. Stein T.R. DeMeester L. Bonavina W. Schwizer R.A. et al. Hinder Ambulatory 24-h esophageal pH monitoring: Normal values, optimal thresholds, specificity, sensitivity, and reproducibility Am J Gastroenterol 87 1992 1102-1111
6. SAS release 6.12. Cary, NC: SAS Institute Inc. Copyright 1989-1996.
7. Microsoft Excel. Microsoft Corporation; 1997.
8. D.I. Park P.L. Rhee Y.H. Kim I.K. Sung H.J. Son J.J. Kim et al. Role of autonomic dysfunction in patients with functional dyspepsia Dig Liver Dis 33 2001 464-471
9. P.G. Farup O. Hovde R. Torp S. Wetterhus Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern Scand J Gastroenterol 34 1999 575-579
10. N.J. Talley V. Meineche-Schmidt P. Pare M. Duckworth P. Raisanen A. Pap et al. Efficacy of omeprazole in functional dyspepsia: Double-blind, randomized, placebo-controlled trials (the Bond and Opera studies) Aliment Pharmacol Ther 12 1998 1055-1065
11. F. Perri V. Festa E. Grossi N. Garbagna G. Leandro A. Andriulli NUD-LOOK Study Group Dyspepsia and Helicobacter pylori infection: A prospective multicentre observational study Dig Liver Dis 35 2003 157-164
12. L. Marzio G. Cappello E. Ballone Evaluation of dyspeptic symptoms in patients with and without Helicobacter pylori infection and normal upper gastrointestinal endoscopy Dig Liver Dis 35 2003 138-142
13. A.M. Walker P. Szneke L.B. Weatherby L.W. Dicker L.L. Lanza J.E. Loughlin et al. The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada Am J Med 107 1999 356-362
14. R.H. Davis M.H. Clench J.R. Mathias Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms: A double-blind, placebo-controlled study Dig Dis Sci 33 1988 1505-1511
15. N. De Nutte W. Van Ganse M. Witterhulghe P. Defrance Relief of epigastric pain in nonulcer dyspepsia: Controlled trial of the promotility drug cisapride Clin Ther 11 1989 62-68
16. M.C. Champion K.L. MacCannell A.B. Thomson R. Tanton S. Eberhard S.N. Sullivan et al. The Canadian Cisapride NUD Study Group A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia Can J Gastroenterol 11 1997 127-134
17. R.H. Davis M.H. Clench J.R. Mathias Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms: A double-blind, placebo-controlled study Dig Dis Sci 33 1988 1505-1511
18. K. Mine F. Kanazawa M. Hosoi N. Kinukawa C. Kubo Treating nonulcer dyspepsia considering both functional disorders of the digestive system and psychiatric conditions Dig Dis Sci 43 1998 1241-1247